Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Effectiveness of BNT162b2 vaccine against SARS-CoV-2 infection and severe COVID-19 in children aged 5–11 years in Italy: a retrospective analysis of January–April, 2022
Chiara Sacco, Martina Del Manso, Alberto Mateo‐Urdiales, et al.
The Lancet (2022) Vol. 400, Iss. 10346, pp. 97-103
Open Access | Times Cited: 110

Showing 26-50 of 110 citing articles:

Audiological and vestibular symptoms following SARS-CoV-2 infection and COVID-19 vaccination in children aged 5–11 years
Mirko Aldè, Federica Di Berardino, Umberto Ambrosetti, et al.
American Journal of Otolaryngology (2022) Vol. 44, Iss. 1, pp. 103669-103669
Open Access | Times Cited: 25
Calendario de inmunizaciones de la Asociación Española de Pediatría: recomendaciones 2023
Francisco José Álvarez García, María José Cilleruelo Ortega, Javier Álvarez Aldeán, et al.
Anales de Pediatría (2023) Vol. 98, Iss. 1, pp. 58.e1-58.e10
Open Access | Times Cited: 13
COVID-19 vaccines versus pediatric hospitalization
Jaime S. Rosa Duque, Daniel Leung, Ka Man Yip, et al.
Cell Reports Medicine (2023) Vol. 4, Iss. 2, pp. 100936-100936
Open Access | Times Cited: 13
SARS-CoV-2 variants of concern in children and adolescents with COVID-19: a systematic review
Margarethe Wiedenmann, Aziz Mert Ipekci, Lucia Araujo-Chaveron, et al.
BMJ Open (2023) Vol. 13, Iss. 10, pp. e072280-e072280
Open Access | Times Cited: 13
COVID-19 Vaccine Effectiveness Against Omicron Infection and Hospitalization
Pierre‐Philippe Piché‐Renaud, Sarah Swayze, Sarah A. Buchan, et al.
PEDIATRICS (2023) Vol. 151, Iss. 4
Closed Access | Times Cited: 12
COVID-19 vaccination for children aged 5–11 years
Shamez Ladhani
The Lancet (2022) Vol. 400, Iss. 10346, pp. 74-76
Open Access | Times Cited: 19
Effectiveness of BNT162b2 and CoronaVac vaccines in preventing SARS-CoV-2 Omicron infections, hospitalizations, and severe complications in the pediatric population in Hong Kong: a case-control study
Vincent Ka Chun Yan, Franco Wing Tak Cheng, Celine Sze Ling Chui, et al.
Emerging Microbes & Infections (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 11
Policies on children and schools during the SARS-CoV-2 pandemic in Western Europe
Antoni Soriano‐Arandes, Ana Brett, Danilo Buonsenso, et al.
Frontiers in Public Health (2023) Vol. 11
Open Access | Times Cited: 11
Dynamic variations in COVID-19 with the SARS-CoV-2 Omicron variant in Kazakhstan and Pakistan
Qianqian Cui, Zheng‐Li Shi, Duman Yimamaidi, et al.
Infectious Diseases of Poverty (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 10
The impact of quality-adjusted life years on evaluating COVID-19 mitigation strategies: lessons from age-specific vaccination roll-out and variants of concern in Belgium (2020-2022)
Lander Willem, Steven Abrams, Nicolas Franco, et al.
BMC Public Health (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 3
A Comprehensive Review on the Current Vaccines and Their Efficacies to Combat SARS-CoV-2 Variants
Ali A. Rabaan, Abbas Al Mutair, Khalid Hajissa, et al.
Vaccines (2022) Vol. 10, Iss. 10, pp. 1655-1655
Open Access | Times Cited: 15
Immunisation schedule of the Spanish Association of Paediatrics: 2023 Recommendations
Francisco José Álvarez García, María José Cilleruelo Ortega, Javier Álvarez Aldeán, et al.
Anales de Pediatría (English Edition) (2023) Vol. 98, Iss. 1, pp. 58.e1-58.e10
Open Access | Times Cited: 8
Effectiveness of BNT162b2 Vaccine against Omicron Variant Infection among Children 5–11 Years of Age, Israel
Aharona Glatman‐Freedman, Yael Hershkovitz, Rita Dichtiar, et al.
Emerging infectious diseases (2023) Vol. 29, Iss. 4, pp. 771-777
Open Access | Times Cited: 8
Knowledge on Parental Hesitancy toward COVID-19 Vaccination of Children 5–11 Years Old
Susanna Esposito, Cristiano Rosafio, S Partesotti, et al.
Vaccines (2023) Vol. 11, Iss. 3, pp. 587-587
Open Access | Times Cited: 8
Sex-Differential and Non-specific Effects of Vaccines Over the Life Course
Laura A. St Clair, Sabal Chaulagain, Sabra L. Klein, et al.
Current topics in microbiology and immunology (2023), pp. 225-251
Open Access | Times Cited: 8
Real-world effectiveness and causal mediation study of BNT162b2 on long COVID risks in children and adolescents
Qiong Wu, Bingyu Zhang, Jiayi Tong, et al.
EClinicalMedicine (2024) Vol. 79, pp. 102962-102962
Open Access | Times Cited: 2
The BNT162b2 vaccine induces humoral and cellular immune memory to SARS-CoV-2 Wuhan strain and the Omicron variant in children 5 to 11 years of age
Bianca Laura Cinicola, Eva Piano Mortari, Anna Maria Zicari, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 13
Impact of SARS-CoV-2 Infection in Children with Asthma and Impact of COVID-19 Vaccination: Current Evidence and Review of the Literature
Roberto Grandinetti, Elisabetta Palazzolo, Luisa Rizzo, et al.
Microorganisms (2023) Vol. 11, Iss. 7, pp. 1745-1745
Open Access | Times Cited: 6
The awareness and acceptance of anti-COVID 19 vaccination in adolescence
Vita Cupertino, Elena Bozzola, Giampaolo De Luca, et al.
˜The œItalian Journal of Pediatrics/Italian journal of pediatrics (2022) Vol. 48, Iss. 1
Open Access | Times Cited: 10
The immunogenicity of an extended dosing interval of BNT162b2 against SARS-CoV-2 Omicron variant among healthy school-aged children, a randomized controlled trial
Napaporn Chantasrisawad, Chonnamet Techasaensiri, Pope Kosalaraksa, et al.
International Journal of Infectious Diseases (2023) Vol. 130, pp. 52-59
Open Access | Times Cited: 5
Effectiveness of BNT162b2 and CoronaVac vaccines against omicron in children aged 5 to 11 years
Eduardo A. Oliveira, Maria Christina L. Oliveira, Ana Cristina Simões e Silva, et al.
World Journal of Pediatrics (2023) Vol. 19, Iss. 10, pp. 949-960
Open Access | Times Cited: 5
Temporal, age, and geographical variation in vaccine efficacy against infection by the Delta and Omicron variants in the community in France, December 2021 to March 2022
François Blanquart, Clémence Abad, Joëvin Ambroise, et al.
International Journal of Infectious Diseases (2023) Vol. 133, pp. 89-96
Open Access | Times Cited: 5
Real-world Effectiveness of BNT162b2 Against Infection and Severe Diseases in Children and Adolescents
Qiong Wu, Jiayi Tong, Bingyu Zhang, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 5
Considerations for vaccinating children against COVID-19
John Hart, Darren Suryawijaya Ong, Kulkanya Chokephaibulkit, et al.
BMJ Paediatrics Open (2023) Vol. 7, Iss. 1, pp. e001964-e001964
Open Access | Times Cited: 5
Association of Prior COVID-19 Vaccination With SARS-CoV-2 Infection and Death in Children and Young Persons During the Omicron Variant Period in Brazil
Eduardo A. Oliveira, Maria Christina L. Oliveira, Ana Cristina Simões e Silva, et al.
JAMA Pediatrics (2023) Vol. 177, Iss. 10, pp. 1100-1100
Open Access | Times Cited: 5

Scroll to top